I write about healthcare and all things pharma

Search Tweets

Twitter Feed

@Jessicaemerrill — 704 followers, 558 tweets

Sep 20, 2017

The insurer still benefits (but only in the near-term), and I can't help but wonder what would happen if the payers just said no. https://t.co/HietNtVlW9

Sep 20, 2017

$PFE lawsuit: J&J denies rebates on ALL Remicade prescriptions if ANY infliximab biosimilar prescriptions are reimbursed.

Sep 20, 2017

J&J's exclusive Remicade contracts are a big test for biosimilars. My q is what role do payers have to reject them to foster the market?

Show more